SIC
SJS Investment Consulting’s BioCryst Pharmaceuticals BCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-20
| Closed | -$102 | – | 1668 |
|
|
2024
Q1 | $102 | Buy |
20
+2
| +11% | +$10 | ﹤0.01% | 1565 |
|
|
2023
Q4 | $108 | Sell |
18
-7
| -28% | -$42 | ﹤0.01% | 1543 |
|
|
2023
Q3 | $177 | Buy |
25
+11
| +79% | +$78 | ﹤0.01% | 1473 |
|
|
2023
Q2 | $99 | Hold |
14
| – | – | ﹤0.01% | 1514 |
|
|
2023
Q1 | $117 | Sell |
14
-12
| -46% | -$100 | ﹤0.01% | 1443 |
|
|
2022
Q4 | $298 | Buy |
26
+14
| +117% | +$160 | ﹤0.01% | 1345 |
|
|
2022
Q3 | $0 | Buy |
+12
| New | – | ﹤0.01% | 1059 |
|
|
2022
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 737 |
|